Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2025Journal of Clinical MedicineOpen Access

Novel Biomarkers for Rejection in Kidney Transplantation: A Comprehensive Review

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMichael Brad StraderSKSam Kant

Discussion

Loading...

Member takes

Overview

Comprehensive review highlights novel biomarkers that improve diagnostic performance in kidney transplantation, suggesting better immunosuppression management.

Key Points

  • Novel biomarkers offer improved sensitivity for early detection of rejection in kidney transplantation.
  • Conventional monitoring tools like serum creatinine have limitations in identifying graft injury.
  • Biopsies remain the gold standard but are invasive and carry procedural risks.
  • Personalized immunosuppressive strategies can benefit from the use of emerging biomarkers in clinical practice.

Cite This Study

Strader et al. (2025) studied this question.

synapsesocial.com/papers/689a0f93e6551bb0af8d11f7https://doi.org/10.3390/jcm14155489
View Full Paper
Ask AI
Bookmark
Share